Delve into the field of PARP inhibitors, a class that has gained traction in ovarian, breast, and prostate cancers.
Hosted on MSN
Mastering molecular biology from class to lab
From groundbreaking DNA experiments to running PCR and gel electrophoresis in the lab, molecular biology education now blends historic discoveries with modern practice. Students gain skills through a ...
On 25 April 1953, Watson and Crick published an article, in the acclaimed journal “Nature” titled “Molecular structure of nucleic acids: A structure for deoxyribonucleic acid”. The one-page article ...
Phase 3 trial results demonstrate that bepirovirsen significantly increases the proportion of patients achieving functional cure compared with placebo.
Results from Part 1 of the Phase 1b MUIR trial to be presented at annual meeting in June SAN DIEGO, April 21, 2026 (GLOBE NEWSWIRE)-- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical ...
Model Medicines receives US patent related to MDL-001 in its broad antiviral Intellectual Property portfolio: San Diego, California Saturday, April 18, 2026, 12:00 Hrs [IST] Model ...
Compelling Preclinical Activity in Triple-Negative Breast Cancer with Azenosertib ...
Discover 25 facts too weird to be in a textbook! From glass brains to skinless sharks, these bizarre scientific and ...
Researchers at The University of Texas MD Anderson Cancer Center have developed a new imaging method, known as RF-SIRF, that ...
A cancer drug target already being investigated in clinical trials turns out to be doing something even more consequential than researchers realized. Scientists at Scripps Research have discovered ...
When a gene is turned on in a cell, it creates a ripple effect along the DNA strand, changing the physical structure of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results